|
|
|
Hospitals and Health Systems |
|
|
- Continued, significant pressures on cost management and
revenue
recovery.
- Concerns about patient safety driving investment in clinical
systems.
|
|
Employers and Health Insurance |
|
|
- Employer and government cost containment driving consumer
driven product designs.
- Cyclic pressures and newer products will reduce growth
in premium revenues and will drive greater need for further
administrative cost reductions.
- Chronic disease consumes a significant majority of healthcare
pending.
Payers will seek better intelligence about their covered
populations in an effort to target programs for chronic
diseases.
|
|
Pharmaceutical and Life Sciences |
|
|
- Increased scrutiny on drug safety and quality control.
- Pressure to curb costs along the full value chain.
|
|
Our emphasis is on companies that
have strong enabling technology platforms, and are able to drive
significant performance improvement and return on investment
for customers. |